MarketPeel
Insider Trading Intelligence
Pricing
…
KD

Kiernan Thomas Deangelis

HUMA
CHIEF MEDICAL OFFICER · HUMACYTE, INC. · CIK 0001877848
FILING MIX · LIFETIME100%/0%
BUYS
2
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Aug 2021
HOLDINGS NOW
99,576
AVG SELL PX
—
TRADE KIND
SHOWING 2 / 2
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Kiernan Thomas Deangelis. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
HUMA · 99,576 shares · as of Aug 26, 2021
024,89449,78874,68299,576SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
FLOW · 2 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
1,575——1,575Aug 26, 2021Aug 27, 2021 ↗View →
HUMA
HUMACYTE, INC.
PURCHASEGRANT
Stock grant
99,576——99,576Aug 26, 2021Aug 27, 2021 ↗View →
Other insiders · HUMA
Loading peer insiders…
About this filer
CIK 0001877848
ROLE
Chief Medical Officer
PRIMARY
HUMA
COMPANIES
1
ACTIVE SINCE
Aug 2021
MARKETPEEL · /INSIDER/0001877848DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback